Refreshing results…
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
Download from aacrjournals.orgGenomic Landscapes and Hallmarks of Mutant RAS in Human Cancers
UploadTranscriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
UploadMissing publications? Search for publications with a matching author name.